Sunday, 26 June 2022

 

 

LATEST NEWS Vigilance Bureau Recovers 12kg Gold, 3 Kg Silver, Four Iphones From Ias Officer Sanjay Popli’s House 47 years since the Emergency - 1975, BJP observes "Black Day" Lt Governor inaugurates Sukhnag Sozni Embroidery SFURTI Heritage Cluster of JK KVIB at Magam Budgam Lt Governor meets Industry Leaders from J&K Take every measure to restrict the spread of the virus : Dr. Arun Kumar Mehta DDC Reasi listens to public issues at Panchayat Seela DDC Udhampur reviews status of District Capex Budget works 7th anniversary of Smart Cities Mission: JSCL organises bicycle rally for media persons Jal Jevan Mission : DC Doda reviews project execution at district level Committee meeting DDC Chairperson conducts extensive tour of Panchayat Tirchi DC Srinagar stresses on strengthening of infrastructure in the Revenue Department Director RDD Kashmir holds interaction with Programme Officers National Rowing Championship: J&K clinch maiden medal in sub junior category, claim bronze DDC Rajouri reviews maintenance of Water Supply Schemes Cooperative Awareness Camp Sahakar Se Samriddhi organised in Poonch DDC Chairperson discusses maintenance of roads with Chief Engineer MES Farmers’ awareness cum training camp organized at village Subechak 3 day Cleanliness cum beautification drive concludes in PSPS Govt PG College for Women In 100 days, Mann government brings reforms in every major sector of Punjab : Malwinder Singh Kang Director Horticulture Kashmir conducts extensive tour of Baramulla SANJY–2022: Dr Owais inspects readiness, at Shadipora Transit Camp

 

UK study shows 2nd Covid booster gives higher immunity than 1st

XE variant, Omicron Variant, Delta Plus Covid variant, Delta Covid-19 variant, Coronavirus, Health, Research, Study, Researchers, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Oxygen, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Oxygen Concentrator, Remdesivir, Liquid Medical Oxygen, Oximeter

Web Admin

Web Admin

5 Dariya News

London , 10 May 2022

A second Covid-19 booster dose, or the fourth jab against the virus, boosts immunity more than the initial or the third dose, according to a UK trial. The UK rolled out fourth doses to over-75s and those over the age of 12 who are immunosuppressed in April. It is also offered in Israel and Germany. "Fourth-dose Covid-19 mRNA booster vaccines are well tolerated and boost cellular and humoral immunity," scientists wrote in the Lancet Infectious Diseases. Even as short-term protection against infection is likely to fall away quickly, the trial showed that "peak responses after the fourth dose were similar to, and possibly better than, peak responses after the third dose". Prof Saul N. Faust, from the University Hospital Southampton and the team explained that third-dose boosters increase humoral and cellular immunity. And they provide more short-term protection against symptomatic infection with variants of concern, including Omicron, compared with a two-dose schedule. 

However, protection against symptomatic infection wanes rapidly following the second and third doses of Covid-19 vaccines. The new trial showed that the fourth dose can rescue immune responses that have waned since a third jab. "We've demonstrated that a fourth dose of Covid-19 vaccines can produce a substantial boost to both the antibody and cellular immunity when you give them more than six months after the third dose," Faust, who led the trial, was quoted as saying to the Guardian. In the trial, the team analysed data from 133 participants, finding that 14 days after receiving the fourth jab, there was a 1.6-fold increase in antibodies among those who received the Pfizer BioNTech vaccine. More than two-fold increase was observed among those who received the half-dose Moderna jab, compared with 28 days after the third dose, when antibody levels were still at their peak. 

The increase in immunity levels were seen for those over and below 70 years of age. In addition, levels of antibodies and T-cells increased substantially between the day before the fourth vaccination and 14 days after for both types of fourth jab, the report said. "Our results for immunogenicity are also consistent with the little observational evidence on vaccine effectiveness available from Israel, which indicates increased protection against symptomatic infection and severe illness from a fourth-dose booster," the team wrote in the paper. Faust added that those who had little waning of their immune responses before their fourth dose gained only a limited increase in their immune responses as a result of the booster - with similar findings for others who had a recent history of a Covid infection. "That indicates there may be a ceiling, a maximum antibody level with the T-cell response effects," he said.

 

Tags: XE variant , Omicron Variant , Delta Plus Covid variant , Delta Covid-19 variant , Coronavirus , Health , Research , Study , Researchers , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Liquid Medical Oxygen , Oximeter

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD